SCHEMBL5337919

SCHEMBL5337919

O=c1cc(O)c2cc3cccc(O)c3cc2o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.54
CA9 Q16790 3/20 0.54
CA1 P00915 2/20 0.54
ALDH1A1 P00352 5/20 0.53
KDM4E B2RXH2 4/20 0.53
KMT2A Q03164 3/20 0.53
PIM1 P11309 2/20 0.50
DYRK1A Q13627 2/20 0.44
PIM3 Q86V86 1/20 0.44
PIM2 Q9P1W9 1/20 0.44
GRIN2D O15399 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
GRIN2C Q14957 1/20 0.44
MEN1 O00255 2/20 0.43
MAPT P10636 2/20 0.43
AKR1B1 P15121 3/20 0.43
MCL1 Q07820 3/20 0.43
HPGD P15428 3/20 0.41
CYP3A4 P08684 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2762362 0.84 CA12 (0.65) CA12CA9CA1ALDH1A1KDM4E
SCHEMBL5337634 0.82 CTDSP1 (0.53) CA12CA9CA1ALDH1A1KDM4E
SCHEMBL20317245 0.76 MAOA (0.59) CA12CA9CA1ALDH1A1KDM4E
SCHEMBL5340608 0.76 MAOB (0.50) CA12CA9CA1KMT2AMEN1
SCHEMBL2115683 0.75 CYP1A2 (0.62) CA1ALDH1A1KDM4EKMT2AGRIN2D
SCHEMBL29857010 0.75 CYP1A2 (0.62) CA1ALDH1A1KDM4EKMT2AGRIN2D
SCHEMBL23640267 0.75 CA12 (0.49) CA12CA9CA1ALDH1A1KDM4E
SCHEMBL20815924 0.75 MAOA (0.49) CA12CA9CA1ALDH1A1KDM4E
SCHEMBL6365673 0.74 MCL1 (0.68) CA12CA9CA1ALDH1A1KDM4E
SCHEMBL23640376 0.73 KDM4E (0.57) CA12CA9CA1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7208518-B2 Substituted furochromene compounds of antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2007-04-24 US disclosed
US-20060148890-A1 Substituted furochromene compounds of antiinflammatory action PLIVA-LSTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US disclosed
EP-1648901-A1 SUBSTITUTED FUROCHROMENE COMPOUNDS OF ANTIINFLAMMATORY ACTION PLIVA-ISTRAZIVACKI INSTITUT d.o.o. (HR) 2006-04-26 EP disclosed
WO-2005010006-A1 SUBSTITUTED FUROCHROMENE COMPOUNDS OF ANTIINFLAMMATORY ACTION PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148890-A1 Substituted furochromene compounds of antiinflammatory action LTC4S, CYP11B2, CYP11B1 CA12 3303/4885CA9 2752/4885CA1 1868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.